Structure

Physi-Chem Properties

Molecular Weight:  677.28
Volume:  675.857
LogP:  4.128
LogD:  3.005
LogS:  -4.083
# Rotatable Bonds:  11
TPSA:  175.62
# H-Bond Aceptor:  12
# H-Bond Donor:  2
# Rings:  6
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.324
Synthetic Accessibility Score:  5.292
Fsp3:  0.568
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.364
MDCK Permeability:  6.087969450163655e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.016
Human Intestinal Absorption (HIA):  0.025
20% Bioavailability (F20%):  0.984
30% Bioavailability (F30%):  0.933

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.5
Plasma Protein Binding (PPB):  84.65768432617188%
Volume Distribution (VD):  1.559
Pgp-substrate:  14.438405990600586%

ADMET: Metabolism

CYP1A2-inhibitor:  0.023
CYP1A2-substrate:  0.075
CYP2C19-inhibitor:  0.173
CYP2C19-substrate:  0.094
CYP2C9-inhibitor:  0.772
CYP2C9-substrate:  0.063
CYP2D6-inhibitor:  0.079
CYP2D6-substrate:  0.036
CYP3A4-inhibitor:  0.912
CYP3A4-substrate:  0.481

ADMET: Excretion

Clearance (CL):  5.398
Half-life (T1/2):  0.512

ADMET: Toxicity

hERG Blockers:  0.492
Human Hepatotoxicity (H-HT):  0.365
Drug-inuced Liver Injury (DILI):  0.963
AMES Toxicity:  0.009
Rat Oral Acute Toxicity:  0.096
Maximum Recommended Daily Dose:  0.029
Skin Sensitization:  0.104
Carcinogencity:  0.076
Eye Corrosion:  0.003
Eye Irritation:  0.055
Respiratory Toxicity:  0.249

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC14116

Natural Product ID:  NPC14116
Common Name*:   Euphorbialoid B
IUPAC Name:   n.a.
Synonyms:   euphorbialoid B
Standard InCHIKey:  ZBRDJTDBVDPIHK-JHMQMCJESA-N
Standard InCHI:  InChI=1S/C37H43NO11/c1-19-16-37(45)27(28(19)48-21(3)40)30(49-32(42)22-11-8-7-9-12-22)36(18-46-31(41)23-13-10-14-38-17-23)25(47-20(2)39)15-24-26(34(24,4)5)29(36)35(6,44)33(37)43/h7-14,17,19,24-30,44-45H,15-16,18H2,1-6H3/t19-,24-,25+,26-,27+,28-,29-,30+,35-,36+,37+/m0/s1
SMILES:  C[C@H]1C[C@]2([C@H]([C@H]1OC(=O)C)[C@H]([C@]1(COC(=O)c3cccnc3)[C@@H](C[C@H]3[C@@H]([C@H]1[C@@](C)(C2=O)O)C3(C)C)OC(=O)C)OC(=O)c1ccccc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2030580
PubChem CID:   60168053
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0002966] Tetracarboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota Roots Kunming, Yunnan Province, China 2010-JUL PMID[21928782]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota n.a. root n.a. PMID[21928782]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[22560584]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota Roots n.a. n.a. PMID[7775985]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO12377 Euphorbia prolifera Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus IC50 = 15600.0 nM PMID[531403]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC14116 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC285411
0.995 High Similarity NPC134384
0.995 High Similarity NPC311196
0.9333 High Similarity NPC213143
0.9289 High Similarity NPC238278
0.9059 High Similarity NPC470190
0.9034 High Similarity NPC187494
0.8962 High Similarity NPC475601
0.8957 High Similarity NPC328154
0.8957 High Similarity NPC233727
0.8927 High Similarity NPC470189
0.8927 High Similarity NPC40919
0.8925 High Similarity NPC96801
0.8925 High Similarity NPC150698
0.8905 High Similarity NPC477912
0.8883 High Similarity NPC323551
0.8883 High Similarity NPC476467
0.8883 High Similarity NPC280473
0.8852 High Similarity NPC319556
0.8852 High Similarity NPC62367
0.8846 High Similarity NPC62844
0.8846 High Similarity NPC193361
0.8841 High Similarity NPC51008
0.8841 High Similarity NPC41724
0.881 High Similarity NPC84815
0.881 High Similarity NPC216428
0.881 High Similarity NPC301368
0.8804 High Similarity NPC471016
0.8796 High Similarity NPC469748
0.8785 High Similarity NPC124029
0.8785 High Similarity NPC211920
0.8756 High Similarity NPC477907
0.8756 High Similarity NPC470306
0.8756 High Similarity NPC207531
0.8756 High Similarity NPC42678
0.8756 High Similarity NPC477909
0.8738 High Similarity NPC148860
0.8716 High Similarity NPC35208
0.8714 High Similarity NPC475408
0.8714 High Similarity NPC471014
0.8714 High Similarity NPC6981
0.8708 High Similarity NPC4421
0.8708 High Similarity NPC228331
0.8708 High Similarity NPC319128
0.8702 High Similarity NPC472553
0.8692 High Similarity NPC477902
0.8685 High Similarity NPC127026
0.8685 High Similarity NPC127720
0.8673 High Similarity NPC294579
0.8673 High Similarity NPC144779
0.8667 High Similarity NPC477910
0.8645 High Similarity NPC471980
0.8643 High Similarity NPC253482
0.8611 High Similarity NPC146824
0.8598 High Similarity NPC477911
0.8585 High Similarity NPC75600
0.8585 High Similarity NPC6576
0.8585 High Similarity NPC212768
0.8585 High Similarity NPC473115
0.8585 High Similarity NPC473089
0.8585 High Similarity NPC158020
0.8578 High Similarity NPC473689
0.8578 High Similarity NPC477906
0.8578 High Similarity NPC292416
0.8571 High Similarity NPC165837
0.8571 High Similarity NPC475362
0.8558 High Similarity NPC57797
0.8558 High Similarity NPC48042
0.8558 High Similarity NPC472550
0.8558 High Similarity NPC250807
0.8558 High Similarity NPC76565
0.8558 High Similarity NPC304179
0.8551 High Similarity NPC477903
0.8545 High Similarity NPC472555
0.8539 High Similarity NPC320324
0.8539 High Similarity NPC319880
0.8539 High Similarity NPC244839
0.8531 High Similarity NPC264674
0.8527 High Similarity NPC475648
0.8525 High Similarity NPC328186
0.8525 High Similarity NPC475600
0.8525 High Similarity NPC87152
0.8525 High Similarity NPC122968
0.8525 High Similarity NPC476110
0.8525 High Similarity NPC477787
0.8525 High Similarity NPC228377
0.8525 High Similarity NPC475631
0.8519 High Similarity NPC475137
0.8519 High Similarity NPC475498
0.8519 High Similarity NPC473850
0.8519 High Similarity NPC26881
0.85 High Similarity NPC237702
0.8486 Intermediate Similarity NPC470486
0.8486 Intermediate Similarity NPC471190
0.8486 Intermediate Similarity NPC475644
0.8486 Intermediate Similarity NPC471977
0.8462 Intermediate Similarity NPC475426
0.8462 Intermediate Similarity NPC475406
0.8451 Intermediate Similarity NPC477908
0.8451 Intermediate Similarity NPC206343
0.8439 Intermediate Similarity NPC470279
0.8433 Intermediate Similarity NPC477899
0.8433 Intermediate Similarity NPC477900
0.8426 Intermediate Similarity NPC477788
0.8426 Intermediate Similarity NPC235364
0.8423 Intermediate Similarity NPC38959
0.8423 Intermediate Similarity NPC327904
0.8421 Intermediate Similarity NPC63041
0.8419 Intermediate Similarity NPC477901
0.8409 Intermediate Similarity NPC316841
0.8409 Intermediate Similarity NPC475596
0.8409 Intermediate Similarity NPC475303
0.8394 Intermediate Similarity NPC473506
0.8381 Intermediate Similarity NPC472752
0.8371 Intermediate Similarity NPC30456
0.8364 Intermediate Similarity NPC91125
0.8296 Intermediate Similarity NPC327769
0.8278 Intermediate Similarity NPC289086
0.8253 Intermediate Similarity NPC475315
0.8253 Intermediate Similarity NPC324619
0.8214 Intermediate Similarity NPC170751
0.821 Intermediate Similarity NPC475533
0.8148 Intermediate Similarity NPC30570
0.8113 Intermediate Similarity NPC475835
0.8077 Intermediate Similarity NPC471015
0.8059 Intermediate Similarity NPC473833
0.8043 Intermediate Similarity NPC53255
0.8043 Intermediate Similarity NPC326930
0.8043 Intermediate Similarity NPC85879
0.8043 Intermediate Similarity NPC475301
0.8009 Intermediate Similarity NPC292517
0.8008 Intermediate Similarity NPC13603
0.7945 Intermediate Similarity NPC162812
0.7931 Intermediate Similarity NPC471013
0.7931 Intermediate Similarity NPC148896
0.7931 Intermediate Similarity NPC180668
0.7885 Intermediate Similarity NPC103230
0.7854 Intermediate Similarity NPC476090
0.7842 Intermediate Similarity NPC328928
0.7797 Intermediate Similarity NPC10904
0.7769 Intermediate Similarity NPC471978
0.7729 Intermediate Similarity NPC471004
0.7673 Intermediate Similarity NPC471979
0.7569 Intermediate Similarity NPC309498
0.7489 Intermediate Similarity NPC253314
0.7477 Intermediate Similarity NPC109922
0.7441 Intermediate Similarity NPC44354
0.744 Intermediate Similarity NPC471997
0.7421 Intermediate Similarity NPC470280
0.7407 Intermediate Similarity NPC320748
0.7407 Intermediate Similarity NPC324245
0.7385 Intermediate Similarity NPC328559
0.7385 Intermediate Similarity NPC155792
0.7385 Intermediate Similarity NPC32451
0.7366 Intermediate Similarity NPC111732
0.7353 Intermediate Similarity NPC37473
0.7339 Intermediate Similarity NPC79223
0.7285 Intermediate Similarity NPC477043
0.7281 Intermediate Similarity NPC141385
0.7281 Intermediate Similarity NPC329024
0.7269 Intermediate Similarity NPC135950
0.7253 Intermediate Similarity NPC57690
0.7238 Intermediate Similarity NPC471583
0.7238 Intermediate Similarity NPC471782
0.722 Intermediate Similarity NPC156044
0.7215 Intermediate Similarity NPC103361
0.7197 Intermediate Similarity NPC278540
0.7189 Intermediate Similarity NPC146724
0.7173 Intermediate Similarity NPC70155
0.7169 Intermediate Similarity NPC317672
0.7169 Intermediate Similarity NPC59033
0.7167 Intermediate Similarity NPC235885
0.7137 Intermediate Similarity NPC267926
0.713 Intermediate Similarity NPC12944
0.713 Intermediate Similarity NPC25442
0.7119 Intermediate Similarity NPC311451
0.711 Intermediate Similarity NPC21483
0.711 Intermediate Similarity NPC198205
0.7091 Intermediate Similarity NPC311054
0.7091 Intermediate Similarity NPC112752
0.7089 Intermediate Similarity NPC290529
0.7082 Intermediate Similarity NPC106593
0.7072 Intermediate Similarity NPC136573
0.7072 Intermediate Similarity NPC176371
0.7067 Intermediate Similarity NPC249614
0.7065 Intermediate Similarity NPC107287
0.7062 Intermediate Similarity NPC164340
0.7056 Intermediate Similarity NPC131273
0.7056 Intermediate Similarity NPC473441
0.7051 Intermediate Similarity NPC266192
0.7051 Intermediate Similarity NPC114974
0.7048 Intermediate Similarity NPC314834
0.7045 Intermediate Similarity NPC198390
0.7033 Intermediate Similarity NPC191310
0.7032 Intermediate Similarity NPC476212
0.7032 Intermediate Similarity NPC476205
0.7032 Intermediate Similarity NPC476206
0.7032 Intermediate Similarity NPC259791
0.7032 Intermediate Similarity NPC476256
0.7032 Intermediate Similarity NPC476257

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC14116 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7745 Intermediate Similarity NPD8468 Phase 2
0.7734 Intermediate Similarity NPD8304 Clinical (unspecified phase)
0.7678 Intermediate Similarity NPD5975 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD7396 Approved
0.7244 Intermediate Similarity NPD7927 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7707 Approved
0.7157 Intermediate Similarity NPD6635 Approved
0.7105 Intermediate Similarity NPD3795 Approved
0.7105 Intermediate Similarity NPD3794 Approved
0.708 Intermediate Similarity NPD6529 Discontinued
0.7061 Intermediate Similarity NPD7069 Discontinued
0.7044 Intermediate Similarity NPD820 Phase 3
0.7042 Intermediate Similarity NPD5891 Approved
0.7037 Intermediate Similarity NPD1483 Discontinued
0.7022 Intermediate Similarity NPD7010 Phase 3
0.7013 Intermediate Similarity NPD8326 Phase 3
0.7013 Intermediate Similarity NPD8327 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD8325 Phase 3
0.699 Remote Similarity NPD5088 Discontinued
0.6987 Remote Similarity NPD6657 Clinical (unspecified phase)
0.6986 Remote Similarity NPD485 Clinical (unspecified phase)
0.6978 Remote Similarity NPD6987 Phase 1
0.6978 Remote Similarity NPD3947 Discontinued
0.6943 Remote Similarity NPD4417 Approved
0.6934 Remote Similarity NPD5751 Clinical (unspecified phase)
0.6897 Remote Similarity NPD3389 Approved
0.6897 Remote Similarity NPD3394 Approved
0.6897 Remote Similarity NPD3393 Approved
0.6886 Remote Similarity NPD2510 Approved
0.6886 Remote Similarity NPD2509 Approved
0.6885 Remote Similarity NPD7886 Phase 2
0.6885 Remote Similarity NPD7885 Phase 2
0.6881 Remote Similarity NPD7234 Approved
0.6881 Remote Similarity NPD7233 Approved
0.6866 Remote Similarity NPD9271 Approved
0.6833 Remote Similarity NPD5801 Clinical (unspecified phase)
0.6829 Remote Similarity NPD6026 Approved
0.6822 Remote Similarity NPD4301 Approved
0.6818 Remote Similarity NPD2336 Approved
0.6814 Remote Similarity NPD5721 Clinical (unspecified phase)
0.6809 Remote Similarity NPD6770 Approved
0.68 Remote Similarity NPD6525 Clinical (unspecified phase)
0.6786 Remote Similarity NPD53 Approved
0.6786 Remote Similarity NPD7778 Approved
0.6786 Remote Similarity NPD4987 Clinical (unspecified phase)
0.6786 Remote Similarity NPD7777 Approved
0.6784 Remote Similarity NPD2121 Clinical (unspecified phase)
0.678 Remote Similarity NPD3280 Approved
0.6776 Remote Similarity NPD6642 Approved
0.6776 Remote Similarity NPD6641 Approved
0.6766 Remote Similarity NPD7878 Phase 2
0.6758 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6756 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6754 Remote Similarity NPD2831 Approved
0.6724 Remote Similarity NPD5475 Discontinued
0.6712 Remote Similarity NPD4376 Phase 3
0.671 Remote Similarity NPD4506 Discontinued
0.6697 Remote Similarity NPD8063 Discontinued
0.6696 Remote Similarity NPD2307 Discontinued
0.6694 Remote Similarity NPD8052 Clinical (unspecified phase)
0.6683 Remote Similarity NPD9075 Approved
0.6683 Remote Similarity NPD9074 Approved
0.6682 Remote Similarity NPD4948 Discontinued
0.6667 Remote Similarity NPD8485 Approved
0.6653 Remote Similarity NPD3326 Clinical (unspecified phase)
0.6653 Remote Similarity NPD4989 Phase 2
0.6639 Remote Similarity NPD8479 Phase 2
0.6607 Remote Similarity NPD6361 Phase 2
0.6606 Remote Similarity NPD8021 Approved
0.6606 Remote Similarity NPD6791 Phase 2
0.6606 Remote Similarity NPD8020 Approved
0.6599 Remote Similarity NPD8409 Suspended
0.6594 Remote Similarity NPD6477 Clinical (unspecified phase)
0.6591 Remote Similarity NPD6241 Phase 1
0.6589 Remote Similarity NPD7708 Approved
0.6579 Remote Similarity NPD4396 Clinical (unspecified phase)
0.6579 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6575 Remote Similarity NPD7962 Phase 2
0.6574 Remote Similarity NPD7967 Discontinued
0.6571 Remote Similarity NPD2511 Approved
0.6567 Remote Similarity NPD107 Approved
0.6559 Remote Similarity NPD3006 Discontinued
0.6555 Remote Similarity NPD1926 Approved
0.6552 Remote Similarity NPD7803 Approved
0.6549 Remote Similarity NPD7061 Clinical (unspecified phase)
0.6547 Remote Similarity NPD8360 Approved
0.6547 Remote Similarity NPD8435 Approved
0.6547 Remote Similarity NPD8361 Approved
0.6545 Remote Similarity NPD4373 Phase 2
0.6537 Remote Similarity NPD6323 Clinical (unspecified phase)
0.6537 Remote Similarity NPD5901 Discontinued
0.6531 Remote Similarity NPD6962 Phase 2
0.6531 Remote Similarity NPD7688 Phase 1
0.6529 Remote Similarity NPD3925 Approved
0.6529 Remote Similarity NPD7269 Clinical (unspecified phase)
0.6522 Remote Similarity NPD7187 Phase 2
0.652 Remote Similarity NPD6790 Phase 1
0.6516 Remote Similarity NPD4889 Approved
0.6515 Remote Similarity NPD6995 Phase 1
0.6515 Remote Similarity NPD8356 Approved
0.6511 Remote Similarity NPD7470 Discontinued
0.6509 Remote Similarity NPD4862 Clinical (unspecified phase)
0.6504 Remote Similarity NPD4427 Phase 2
0.6502 Remote Similarity NPD8289 Discontinued
0.649 Remote Similarity NPD4952 Phase 3
0.6481 Remote Similarity NPD7562 Approved
0.6476 Remote Similarity NPD6226 Phase 3
0.6471 Remote Similarity NPD5490 Discontinued
0.6471 Remote Similarity NPD5482 Discontinued
0.6468 Remote Similarity NPD2896 Discontinued
0.6463 Remote Similarity NPD8372 Clinical (unspecified phase)
0.646 Remote Similarity NPD4528 Approved
0.646 Remote Similarity NPD4526 Approved
0.646 Remote Similarity NPD4529 Approved
0.6458 Remote Similarity NPD7404 Approved
0.6457 Remote Similarity NPD6257 Clinical (unspecified phase)
0.6456 Remote Similarity NPD1270 Approved
0.6454 Remote Similarity NPD7417 Discontinued
0.6448 Remote Similarity NPD8091 Phase 3
0.6434 Remote Similarity NPD5640 Discontinued
0.6422 Remote Similarity NPD5100 Phase 3
0.6422 Remote Similarity NPD6176 Phase 1
0.6417 Remote Similarity NPD7395 Discontinued
0.6416 Remote Similarity NPD6665 Discontinued
0.641 Remote Similarity NPD3371 Approved
0.6408 Remote Similarity NPD8430 Approved
0.6402 Remote Similarity NPD8160 Phase 2
0.6398 Remote Similarity NPD2581 Approved
0.6398 Remote Similarity NPD2582 Approved
0.6398 Remote Similarity NPD6262 Clinical (unspecified phase)
0.6395 Remote Similarity NPD3946 Clinical (unspecified phase)
0.639 Remote Similarity NPD6955 Clinical (unspecified phase)
0.6389 Remote Similarity NPD7576 Discontinued
0.6388 Remote Similarity NPD4551 Phase 2
0.6387 Remote Similarity NPD7571 Clinical (unspecified phase)
0.6383 Remote Similarity NPD7947 Clinical (unspecified phase)
0.6383 Remote Similarity NPD7467 Discontinued
0.638 Remote Similarity NPD7414 Clinical (unspecified phase)
0.6378 Remote Similarity NPD5483 Clinical (unspecified phase)
0.6376 Remote Similarity NPD5003 Discontinued
0.6375 Remote Similarity NPD8000 Clinical (unspecified phase)
0.6375 Remote Similarity NPD6825 Phase 1
0.6372 Remote Similarity NPD6446 Discontinued
0.6368 Remote Similarity NPD7957 Phase 1
0.6368 Remote Similarity NPD7958 Clinical (unspecified phase)
0.6367 Remote Similarity NPD8350 Clinical (unspecified phase)
0.6364 Remote Similarity NPD6479 Discontinued
0.6364 Remote Similarity NPD8248 Clinical (unspecified phase)
0.6364 Remote Similarity NPD5827 Discontinued
0.6364 Remote Similarity NPD8412 Phase 1
0.636 Remote Similarity NPD7955 Approved
0.636 Remote Similarity NPD8112 Clinical (unspecified phase)
0.636 Remote Similarity NPD7956 Approved
0.6359 Remote Similarity NPD6739 Clinical (unspecified phase)
0.6356 Remote Similarity NPD5022 Discontinued
0.6355 Remote Similarity NPD1631 Approved
0.6352 Remote Similarity NPD5513 Phase 2
0.6349 Remote Similarity NPD4429 Discontinued
0.6345 Remote Similarity NPD5866 Approved
0.6339 Remote Similarity NPD4375 Approved
0.6337 Remote Similarity NPD4923 Phase 1
0.6337 Remote Similarity NPD6298 Discontinued
0.6335 Remote Similarity NPD5805 Approved
0.6332 Remote Similarity NPD5512 Phase 3
0.633 Remote Similarity NPD6183 Clinical (unspecified phase)
0.633 Remote Similarity NPD6182 Approved
0.633 Remote Similarity NPD43 Approved
0.6329 Remote Similarity NPD7998 Clinical (unspecified phase)
0.6328 Remote Similarity NPD6276 Discontinued
0.6327 Remote Similarity NPD6281 Approved
0.6325 Remote Similarity NPD7712 Clinical (unspecified phase)
0.632 Remote Similarity NPD7807 Clinical (unspecified phase)
0.632 Remote Similarity NPD6874 Approved
0.6314 Remote Similarity NPD7191 Phase 2
0.6312 Remote Similarity NPD7862 Clinical (unspecified phase)
0.6311 Remote Similarity NPD751 Clinical (unspecified phase)
0.6311 Remote Similarity NPD3813 Approved
0.6306 Remote Similarity NPD3178 Discontinued
0.6306 Remote Similarity NPD1783 Clinical (unspecified phase)
0.6304 Remote Similarity NPD7021 Clinical (unspecified phase)
0.6303 Remote Similarity NPD7703 Clinical (unspecified phase)
0.6303 Remote Similarity NPD2809 Approved
0.6298 Remote Similarity NPD7001 Phase 3
0.6298 Remote Similarity NPD4901 Clinical (unspecified phase)
0.6298 Remote Similarity NPD6732 Clinical (unspecified phase)
0.6296 Remote Similarity NPD4174 Clinical (unspecified phase)
0.6296 Remote Similarity NPD1996 Discontinued
0.6295 Remote Similarity NPD8407 Phase 2
0.6293 Remote Similarity NPD4600 Approved
0.6293 Remote Similarity NPD4501 Approved
0.6293 Remote Similarity NPD4601 Approved
0.6293 Remote Similarity NPD4500 Approved
0.629 Remote Similarity NPD1620 Clinical (unspecified phase)
0.6286 Remote Similarity NPD5965 Clinical (unspecified phase)
0.6284 Remote Similarity NPD8373 Clinical (unspecified phase)
0.6281 Remote Similarity NPD3354 Phase 2
0.6281 Remote Similarity NPD6578 Clinical (unspecified phase)
0.6278 Remote Similarity NPD8658 Clinical (unspecified phase)
0.6275 Remote Similarity NPD6292 Clinical (unspecified phase)
0.6275 Remote Similarity NPD7268 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data